Veraxa Biotech AG announced on June 18, 2026, the generation of new in vitro proof-of-concept proof of concept data validating its BiTAC-ADC technology platform. The company is seeking partnering opportunities through discussions at the BIO International Convention 2026. Veraxa Biotech AG operates in the biotechnology industry and develops BiTAC-ADC technology.
